Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-07-001309
Filing Date
2007-03-01
Accepted
2007-03-01 16:24:16
Documents
16
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 INVERNESS MEDICAL INNOVATIONS, INC. b63761ime10vk.htm 10-K 2051958
2 EX-2.10 ASSET PURCHASE AGREEMENT b63761imexv2w10.txt EX-2.10 196696
3 EX-2.11 CONTRIBUTION AGREEMENT b63761imexv2w11.txt EX-2.11 198433
4 EX-3.4 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION b63761imexv3w4.txt EX-3.4 2050
5 EX-3.5 CERTIFICATE OF CORRECTION b63761imexv3w5.txt EX-3.5 2388
6 EX-10.28 NINTH AMENDMENT AND CONSENT TO THIRD AMENDED AND RESTATED CREDIT AGREEM b63761imexv10w28.txt EX-10.28 57709
7 EX-10.40 SUBUNDERLEASE, DATED 15 FEBRUARY 2007 b63761imexv10w40.txt EX-10.40 119259
8 EX-10.41 AMENDMENT NO. 4 TO 2001 STOCK OPTION AND INCENTIVE PLAN b63761imexv10w41.txt EX-10.41 5002
9 EX-10.42 AMENDMENT NO. 5 TO 2001 STOCK OPTION AND INCENTIVE PLAN b63761imexv10w42.txt EX-10.42 1078
10 EX-14.50 BUSINESS CONDUCT GUIDELINES b63761imexv14w50.txt EX-14.50 47921
11 EX-21.1 LIST OF SUBSIDIARIES b63761imexv21w1.txt EX-21.1 5315
12 EX-23.1 CONSENT OF BDO SEIDMAN, LLP b63761imexv23w1.txt EX-23.1 1206
13 EX-31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b63761imexv31w1.txt EX-31.1 3723
14 EX-31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER b63761imexv31w2.txt EX-31.2 3656
15 EX-32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER b63761imexv32w1.txt EX-32.1 2670
16 GRAPHIC b63761imb6376102.gif GRAPHIC 9627
  Complete submission text file 0000950135-07-001309.txt   2714020
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16789 | Film No.: 07663699
SIC: 2835 In Vitro & In Vivo Diagnostic Substances